NeuroCRU
@neurocru.bsky.social
Clinical Research Unit at the Montreal Neurological Institute-Hospital - a leading centre affiliated with McGill University | L'Unité de recherche clinique de l'Institut-hôpital neurologique de Montréal, un centre de pointe affilié à l'Université McGill
Exec dir Ziv Gan-Or spoke at IRBD StudyGroup's annual meeting, discussing the importance of using human-derived data and models in identifying and testing new treatments for #RBD, #Parkinsons, dementia. He also shared his lab’s latest findings of potential genes + biological pathways involved in RBD
June 2, 2025 at 4:49 PM
Exec dir Ziv Gan-Or spoke at IRBD StudyGroup's annual meeting, discussing the importance of using human-derived data and models in identifying and testing new treatments for #RBD, #Parkinsons, dementia. He also shared his lab’s latest findings of potential genes + biological pathways involved in RBD
🔬Plusieurs nouveaux essais cliniques visant à ralentir la progression de la #SP débuteront bientôt au NeuroCRU.
🩺Several new studies aiming to slow the progression of #MS starting soon at Neuro CRU.
📩Info: cru.mcgill.ca/ms or ms-cru.neuro@mcgill.ca.
🩺Several new studies aiming to slow the progression of #MS starting soon at Neuro CRU.
📩Info: cru.mcgill.ca/ms or ms-cru.neuro@mcgill.ca.
May 27, 2025 at 3:08 PM
🔬Plusieurs nouveaux essais cliniques visant à ralentir la progression de la #SP débuteront bientôt au NeuroCRU.
🩺Several new studies aiming to slow the progression of #MS starting soon at Neuro CRU.
📩Info: cru.mcgill.ca/ms or ms-cru.neuro@mcgill.ca.
🩺Several new studies aiming to slow the progression of #MS starting soon at Neuro CRU.
📩Info: cru.mcgill.ca/ms or ms-cru.neuro@mcgill.ca.
Cyrena Gerardi, gestionnaire des opérations à l'URC et Dr Simon Ducharme, chercheur principal, ont assisté au Forum Recherche clinique présenté par @Catalisquebec. Une journée réunissant chercheurs et dirigeants de l'écosystème des sciences de la vie pour faire avancer la #rechercheclinique au #QC.
May 20, 2025 at 3:31 PM
Cyrena Gerardi, gestionnaire des opérations à l'URC et Dr Simon Ducharme, chercheur principal, ont assisté au Forum Recherche clinique présenté par @Catalisquebec. Une journée réunissant chercheurs et dirigeants de l'écosystème des sciences de la vie pour faire avancer la #rechercheclinique au #QC.
#EARTHDAY: The Neuro’s #GreenLabs have made huge strides in reducing research-related plastic waste: 180,000 cu. ft. of expired lab material were diverted to nursing schools in Montreal and 2000 lbs. of ice packs were repurposed by community organizations to help fight food insecurity. #mcgill
April 22, 2025 at 1:48 PM
#EARTHDAY: The Neuro’s #GreenLabs have made huge strides in reducing research-related plastic waste: 180,000 cu. ft. of expired lab material were diverted to nursing schools in Montreal and 2000 lbs. of ice packs were repurposed by community organizations to help fight food insecurity. #mcgill
NeuroCRU exec dir @zivganor.bsky.social
gave a keynote talk at #SleepEurope virtual congress discussing his lab’s work on the genetics of REM Sleep Behavior Disorder #RBD, allowing researchers to find #genetic targets like #GBA1 for #drugdevelopment and to identify patients best suited to trials.
gave a keynote talk at #SleepEurope virtual congress discussing his lab’s work on the genetics of REM Sleep Behavior Disorder #RBD, allowing researchers to find #genetic targets like #GBA1 for #drugdevelopment and to identify patients best suited to trials.
April 3, 2025 at 1:55 PM
NeuroCRU exec dir @zivganor.bsky.social
gave a keynote talk at #SleepEurope virtual congress discussing his lab’s work on the genetics of REM Sleep Behavior Disorder #RBD, allowing researchers to find #genetic targets like #GBA1 for #drugdevelopment and to identify patients best suited to trials.
gave a keynote talk at #SleepEurope virtual congress discussing his lab’s work on the genetics of REM Sleep Behavior Disorder #RBD, allowing researchers to find #genetic targets like #GBA1 for #drugdevelopment and to identify patients best suited to trials.
Neuro CRU's Ziv Gan-Or leads the GBA1-Canada initiative, an open science platform dedicated to advancing research and treatment for #Parkinsons due to mutations in the #GBA1 gene. GBA1-CAN international conference: June 5-7. Deadline for abstracts: March 31. Register: lnkd.in/eNbQBhvW
March 27, 2025 at 4:27 PM
Neuro CRU's Ziv Gan-Or leads the GBA1-Canada initiative, an open science platform dedicated to advancing research and treatment for #Parkinsons due to mutations in the #GBA1 gene. GBA1-CAN international conference: June 5-7. Deadline for abstracts: March 31. Register: lnkd.in/eNbQBhvW
If you can use a smartphone, you could help move #Parkinsons research forward! Healthy participants over 60 are needed to test a smartphone app that aims to detect subtle changes in movement and better track the progression of the disease. For info: cru.mcgill.ca/mvtdisorders (514) 398-5500.
March 20, 2025 at 4:38 PM
If you can use a smartphone, you could help move #Parkinsons research forward! Healthy participants over 60 are needed to test a smartphone app that aims to detect subtle changes in movement and better track the progression of the disease. For info: cru.mcgill.ca/mvtdisorders (514) 398-5500.
Grande nouvelle! Des recherches cliniques menées au Neuro ont permis de valider une thérapie révolutionnaire qui peut ralentir la progression de la #SLA de type #SOD1. #SantéCanada a accordé une approbation conditionnelle au #Tofersen maintenant appelé #Qalsody. Entrevue: bit.ly/qalsodyurc
March 18, 2025 at 2:59 PM
Grande nouvelle! Des recherches cliniques menées au Neuro ont permis de valider une thérapie révolutionnaire qui peut ralentir la progression de la #SLA de type #SOD1. #SantéCanada a accordé une approbation conditionnelle au #Tofersen maintenant appelé #Qalsody. Entrevue: bit.ly/qalsodyurc
A new non-interventional study aims to identify the most common genetic variations of #HuntingtonsDisease to help researchers develop more targeted treatments. This international #clinicaltrial is at 4 sites in Canada, including NeuroCRU. Info: neurocog-cru.neuro@mcgill.ca. cru.mcgill.ca
March 12, 2025 at 1:25 PM
A new non-interventional study aims to identify the most common genetic variations of #HuntingtonsDisease to help researchers develop more targeted treatments. This international #clinicaltrial is at 4 sites in Canada, including NeuroCRU. Info: neurocog-cru.neuro@mcgill.ca. cru.mcgill.ca
CRU exec director @ZivGanOr was in Vienna for #RARE2025 to discuss his lab’s work understanding #GBA1, a genetic mutation behind a rare subtype of #Parkinsons. The CRU works to offer the most advanced investigational therapies for individuals with rare diseases, including RNA and #genetherapy.
March 6, 2025 at 12:24 PM
CRU exec director @ZivGanOr was in Vienna for #RARE2025 to discuss his lab’s work understanding #GBA1, a genetic mutation behind a rare subtype of #Parkinsons. The CRU works to offer the most advanced investigational therapies for individuals with rare diseases, including RNA and #genetherapy.
Les maladies rares neurologiques sont surreprésentées au Québec et les traitements potentiels sont souvent inexistants. La recherche est essentielle. L’Unité de recherche clinique du Neuro élargit la liste des conditions rares couvertes par ses essais cliniques. Études: cru.mcgill.ca/fr/essais.
February 28, 2025 at 5:48 PM
Les maladies rares neurologiques sont surreprésentées au Québec et les traitements potentiels sont souvent inexistants. La recherche est essentielle. L’Unité de recherche clinique du Neuro élargit la liste des conditions rares couvertes par ses essais cliniques. Études: cru.mcgill.ca/fr/essais.